期刊文献+

泛影葡胺脂质体的制备及其肝脏靶向增强效应观察 被引量:2

The Experimental Study on the Preparation of Diatrizoate liposomes and Their Application for Liver Targeting Contrast Enhancement
下载PDF
导出
摘要 目的:探讨泛影葡胺脂质体对肝脏靶向增强的可能。材料和方法:采用乙醚注射法(胆固醇与卵磷脂摩尔比1:1)制备包裹泛影葡胺的大单层脂质体;用CT观察其对大鼠肝炎型假瘤(n=4)的靶向增强效果。结果:(1)所制备的装载泛影葡胺脂质体粒径为0.82±0.32μm,面积为8.4±4.0μm2,体积为6.9±1.3μm3。造影剂包裹率为10.1%。体外稳定试验表明泛影葡胺质体放置3d时,含碘量仍保持93.8%,7d后造影剂大量渗漏,含碘量降至41.8%。(2)泛影葡胺脂质体能靶向性分布于肝脏,使正常组织呈渐进式增强,30min达到高峰,以后逐渐下降,12h后恢复至基础水平。肝炎性假瘤灶在给药后30min显示最佳。结论:泛影葡胺脂质体能有效提高肝脏增强水平,对提高肝脏病变的显示有重要作用。 Purporse: To explore the efficiency and possibility of liposomic diatrizoate as hepatic tissue seeking contrast material in rats. ]Materials and Methods: The large unilamelar liposomes entrapped diatrizoate prepared by ether injection method (egg lecithin/cholesterol in 1:1 molar ratio). Then, The diatrizoate-carrying liposomes were intravenously injected at a dose of 30mg I/rat in 4 rates with pseudo hepatic tumor induced by local injection of Freund' complete adjuvant. The contrast enhancing degree of the liver was evaluated with computed tomography. Results: The diatroziate loading liposomes made here ranged 0.82+0.32 m in diameter, 8.4+4.0m2 in area, 6.9+1.3m3 in volume. The encapsulation efficiency was 10.1%.The stability of the vesicle was determined by means of dialysis. We found 93.8% of iodine remained inside the liposome suspension which stored at 4 for 3 days, while only 418% of iodine left in the liposomes over 7 days. After injection of the liposomes, the normal hepatic tissue show density rise over the next 15 minutes. The maximal enhancement in the liver was reached 30 minutes after injection of the contrast. The liver opacity was gradually decreased over the 60 minutes. Finally, the baseline level was obtained 12 hours after administration of the liposomes. The hepatic pseudotumor lesions were best demonstrated 30 minutes after the injection. Z]Conclusion: The diatroziate-loading liposomes can effectively chang the biodistribution of the diatroziate and results in specifically hepatic uptake. It may improve the detection of small lesions in liver.
出处 《中国医学影像学杂志》 CSCD 1999年第2期122-123,共2页 Chinese Journal of Medical Imaging
关键词 脂质体 泛影葡胺 肝脏 CT liposomes diatroziate liver computed tomography
  • 相关文献

参考文献3

共引文献6

同被引文献41

  • 1ZHANG Zhi Rong, HE Qin, LIAO Gong Tie and BAI Shao Huai.Study on the anticarcinogenic effect and acutetoxicity of liver-targeting mitoxantrone-nanoparticles[J].World Journal of Gastroenterology,1999,5(6):511-514. 被引量:13
  • 2ZHANG Zhi Rong and HE Qin.Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoacrylate nanoparticles *[J].World Journal of Gastroenterology,1999,5(4):55-57. 被引量:3
  • 3祝侠丽,黄桂华,张娜,张丙杰.碘海醇脂质体的研制[J].中国药学杂志,2005,40(12):916-918. 被引量:3
  • 4Seltzer SE, Blau M, Herman LW, et al. Contrast material-carrying liposomes: biodistribution, clearance, and imaging characteristics. Radiology, 1995,194(3) :775-781.
  • 5Ahl PL, Perkins WR. Interdigitation-Fusion liposomes. Methods in Enzymology, 2003,367 : 80-98.
  • 6Ata Erdogan, Charles JD. Recent clinical trials of iodixanol. Rev Cardiovasc Med, 2003,4 (1) : 43-50.
  • 7Kjeken R, Kindberg GM, Berg T. Distribution of liposome-encapsulated iodixanol in rat liver cells, Biochemical Pharmacology, 2000,60(4) : 553-559.
  • 8Leander P, Hoglund P, Borseth A, et al. A new liposomal liver-specific contrast agent for CT: first human phase-I clinical trial assessing efficacy and safety. European Radiology, 2001, 11 (0938-7994) :698-704.
  • 9Spinazzi A, Ceriati S, Pianezzola P, et al, Safety and Pharmaco: kinetics of a New Liposomal Liver-Specific Contrast Agent for CT: Results of Clinical Testing in Nonpatient Volunteers. Investigative Radiology, 2000,35 (1) :1.
  • 10Andreas Sachse. Iodinated Liposomes as Contrast Agents. Nanoparticles in Biomedical Imaging, 2007,102(1559-7083) :371-410.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部